TD ADSORBED DIN 02528401
Status: Marketed
Holder: SANOFI VACCINES CANADA LTD.
Health Canada record
| Active ingredient(s) | DIPHTHERIA TOXOID ADSORBED 2 LF; TETANUS TOXOID ADSORBED 5 LF |
|---|
| Dosage form | Suspension |
|---|
| Route | Intramuscular |
|---|
| Schedule | SCHEDULE D |
|---|
| Class | Human |
|---|
| ATC | J07AM51 TETANUS TOXOID, COMB. WITH DIPHTHERIA TOXOID |
|---|
| Original market date | 09-Apr-2024 |
|---|
| Current status date | 09-Apr-2024 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Sanofi Vaccines Canada Ltd. — licence 101420, currently licensed, last inspection rating C (2026-02-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DIPHTHERIA TOXOID ADSORBED
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02312557 | BOOSTRIX-POLIO | GLAXOSMITHKLINE INC | Suspension | DIPHTHERIA TOXOID ADSORBED 2.5 LF; TETANUS TOXOID ADSORBED 5.0 LF; PERTUSSIS TOXOID ADSORBED 8 MCG; FILAMENTOUS HAEMAGGLUTININ ADSORBED 8 MCG; PERTACTIN ADSORBED 2.5 MCG; INACTIVATED POLIOVIRUS TYPE I 40 D; INACTIVATED POLIOVIRUS TYPE II 8 D; INACTIVATED POLIOVIRUS TYPE III 32 D | Marketed |
| 00514462 | TD ADSORBED | SANOFI VACCINES CANADA LTD. | Suspension | DIPHTHERIA TOXOID ADSORBED 2 LF; TETANUS TOXOID ADSORBED 5 LF | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 28466 | 2022-06-14 | Supplement to a New Drug Submission (SNDS) | 1. New formulation
2. Additional drug product manufacturing site |
Request a quote for TD ADSORBED
How to read a Canadian DIN record